Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 7, 2012

View Archived Issues

High-grade glioma combination therapy enters new trial in U.S.

Pilot study assesses veliparib/temozolomide combination in metastatic CRPC

Long-term trial evaluates safety of liprotamase

New serine protease inhibitors patented by The Medicines Company

BioLineRx signs license agreement for oral hepatitis C treatment

Novel soluble guanylate cyclase activators disclosed by Bayer Schering Pharma

Merck & Co. provides update on development program for suvorexant

OncoTherapy Science and Otsuka begin phase III study of cancer vaccine

GSK voluntarily pauses enrollment in GSK-2251052 trials

Temsirolimus shows limited activity in refractory metastatic urothelial cancer

Research agreement begins for Oxycyte diagnostic and therapeutic tool for stroke

Vertex Pharmaceuticals presents new agents for flavivirus infections

Molecular Insight Pharmaceuticals to evaluate targeted radiopharmaceutical for prostate cancer

TCG Lifesciences achieves milestones in drug discovery partnership

Cantargia targets IL-1RAcP in in vivo model of malignant melanoma

Orexigen reaches agreement with FDA on Contrave outcomes trial

New voltage-gated Na(V)1.7 sodium channel antagonists prepared

Wilex receives grant for PI3K inhibitor

Abbott Laboratories presents novel lysophospholipid receptor agonists

Novartis discloses new protein kinase inhibitors

New vaccines for staphylococcal infection patented by Merck & Co.

New products for Alzheimer's disease patented

Janssen Pharma seeks Japanese approval of Edurant

PharmaGap reports data on GAP-107B8 in models of ovarian cancer

Apricus Biosciences acquires rights to NitroMist

Takeda launches combination tablet for hypertension in U.S.

Study compares apixaban to warfarin in subgroup of ARISTOTLE participants

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...